We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 56

Apotex v. Canada (Minister of Health)
  • Gowling WLG
  • Canada
  • May 28 2009

Apotex brought a judicial review of the Minister’s refusal to issue a NOC regarding its version of aspirin


Lundbeck v. Ratiopharm and Cobalt
  • Gowling WLG
  • Canada
  • May 28 2009

The Court of Appeal upheld the decision of the applications judge who struck the applications for judicial review


Pfizer v. ratiopharm Inc.; interlocutory motion on appeal of impeachment decision
  • Gowling WLG
  • Canada
  • December 3 2009

Pfizer filed a motion to amend the contents of its appeal book, its notice of appeal and its memorandum of fact and law on the appeal to deal with the additional grounds


Eli Lilly v. Canada (Minister of Health)
  • Gowling WLG
  • Canada
  • May 28 2009

Eli Lilly had submitted patent lists seeking to add the newly issued patent at issue to the Patent Register with respect to several supplemental new drug submissions


Novopharm Limited v. Eli Lilly Canada Inc
  • Gowling WLG
  • Canada
  • May 28 2009

The Court of Appeal dismissed the appeal of the generic company from a decision of the motions judge refusing to dismiss the proceeding as a whole


Federal Court of Appeal upholds denial of innovator profits and refuses to grant damages for future lost market share in first case under s. 8 of the PM(NOC) Regulations
  • Gowling WLG
  • Canada
  • June 5 2009

In September 2008, the Federal Court released its first decision interpreting s. 8 of the PM(NOC) Regulations


Law professor criticizes recent court rulings on patent disclosure
  • Gowling WLG
  • Canada
  • September 30 2009

In a recent issue of the Lawyers Weekly, Professor Jeremy de Beer of the University of Ottawa criticizes the uncertainty in Canadian patent law and calls on the Supreme Court to clarify disclosure obligations


Aventis v. Pharmascience; motion to set aside a previous order of prohibition; 2009 FC 915; ramipril; September 15, 2009
  • Gowling WLG
  • Canada
  • September 30 2009

Pharmascience had previously sent an Notice of Allegation (NOA) with respect to a patent to Aventis, resulting in a full hearing and appeal, concluding with an order of prohibition


Janssen-Ortho v. Apotex; motion for a stay; 2009 FCA 250; tramadol and acetaminophen; August 20, 2009
  • Gowling WLG
  • Canada
  • September 30 2009

In the Courts below, Apotex brought a motion to dismiss the application


Apotex v. Pfizer
  • Gowling WLG
  • Canada
  • March 4 2009

The Court of Appeal dismissed the generic company's appeal and upheld the decision of the trial judge prohibiting Apotex entering the market until the expiry of the patent